Previous studies using a Drosophila cancer model and a CUX1 insertion mutation mediated by a mouse transposon found that when CUX1 is deleted, it will abnormally activate the PI3K signaling pathway, thus promoting tumor growth and sensitivity to PI3K/AKT inhibitors (40). The gene discussed is CUX1; the disease is cancer.